- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03538067
Balloon Inflation and Plaque Morphology in Revascularisation (BURST) (BURST)
Influence of Balloon Inflation Techniques and Plaque Characteristics on Stent Under-expansion in Percutaneous RevasculariSaTion (BURST)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients presenting with symptoms of coronary artery disease (e.g. chest pain - angina) are often treated with stents (referred to as percutaneous coronary intervention, PCI). Stents treat the cause of symptoms by improving blood flow to the heart muscle through expanding a narrowed, or diseased segment within a coronary artery. The procedure involves the inflation of a balloon to expand the stent inside the artery. As part of standard clinical care multiple balloon inflations are required during the procedure. Deficiencies in the expansion of the stent at the time of the procedure are associated serious complications such as stent blockages or re-narrowing of the artery, either of which may not occur until much later.
Improvements to the technique of stent expansion are therefore highly desirable to improve outcomes for patients. A number of factors are thought to influence the success of the procedure, including: the type of balloon used to inflate the stent, the pressure used and the duration of balloon inflation. Another important factor may be the mechanical properties of the narrowed segment of the artery (plaque) and how they interact with the stent. At present however, there is no consensus view and the practise of individual cardiologists consequently remains highly variable.
The aim of this study is better characterise relationship between pressure and duration of balloon inflation, type of balloon used and plaque properties during stent procedures using state-of-the-art imaging. Although assessment of each of these factors by a cardiologist is already included as part of standard care, our research protocol will focus the analysis into a systematic framework to allow conclusions to be drawn. The findings will used better inform cardiologists of the technical modifications that can help improve stenting procedures and translate to better outcomes for patients.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with symptomatic coronary artery disease (stable angina, non-ST elevation acute coronary syndromes) undergoing percutaneous coronary intervention with intracoronary ultrasound (IVUS) guidance
- Patients > 18 years
- De novo coronary stenoses in native coronary arteries
- Written informed consent
Exclusion Criteria:
- ST-elevation acute coronary syndrome
- Haemodynamic instability
- Cardiogenic shock
- Severe renal dysfunction (eGFR < 30 ml/min/1.73m2)
- In-stent restenosis
- Chronic total occlusions
- Saphenous vein and arterial bypass grafts
- Patients who are currently enrolled in any other study where involvement in this study would involve significant deviation from either protocol
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Paired sample group
Patients with symptomatic coronary artery disease (stable, NSTEACS) undergoing planned percutaneous coronary intervention with intravascular ultrasound (IVUS) guidance
|
Patients will undergo PCI with intravascular ultrasound (IVUS) as part of standard clinical care in accordance with operator discretion.
The research protocol will be observational - using IVUS to determine the effects of balloon inflation time, balloon inflation pressure, balloon type, atherosclerotic plaque morphology on stent expansion (minimal luminal area, MLA)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In-stent minimal luminal area (MLA, mm2)
Time Frame: Immediate - peri-procedurally
|
As measured by intravascular ultrasound
|
Immediate - peri-procedurally
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plaque characteristics
Time Frame: Immediate - peri-procedural
|
As determined by virtual histology intravascular ultrasound (VH-IVUS)
|
Immediate - peri-procedural
|
|
Stent deployment
Time Frame: Immediate - peri-procedural
|
Determined by intravascular ultrasound (IVUS - MUSIC Criteria)
|
Immediate - peri-procedural
|
|
Peri-procedural myocardial infarction
Time Frame: Immediate - peri-procedural
|
In accordance with academic research consortium (ARC) definition
|
Immediate - peri-procedural
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Simon Redwood, MD FRCP FACC, King's College London, Guy's and St Thomas' Hospital, London
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 212423
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.